Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through beta2 receptor

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 44-51

  Masuda, Takahiro ^a,b   Nakagawa, Shin ^a   Boku, Shuken ^a   Nishikawa, Hiroyuki ^b   Takamura, Naoki ^a,b   Kato, Akiko ^a   Inoue, Takeshi ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Antidepressant drugs; Depression; Hippocampus; Neurogenesis; Progenitor cell; Serotonin

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; FLUOXETINE; IMIPRAMINE; NORADRENALIN; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; REBOXETINE; SALMETEROL; SEROTONIN; TIMOLOL; TRANYLCYPROMINE; YOHIMBINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DNA SYNTHESIS; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME INHIBITION; NEURAL STEM CELL; NONHUMAN; RAT;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DENTATE GYRUS; MALE; NEURAL STEM CELLS; NEUROGENESIS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2;

EID: 82555169803     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.08.019     Document Type: Article

References (48)

1. Abercrombie E.D., Keller R.W., Zigmond M.J. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 1988, 27:897-904.
2. Ahmed S.A., Gogal R.M., Walsh J.E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994, 170:211-224.
3. Airan R.D., Meltzer L.A., Roy M., Gong Y., Chen H., Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007, 317:819-823.
4. Banasr M., Hery M., Printemps R., Daszuta A. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 2004, 29:450-460.
5. Benninghoff J., Gritti A., Rizzi M., Lamorte G., Schloesser R.J., Schmitt A., et al. Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells. Neuropsychopharmacology 2010, 35:893-903.
6. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994, 15:220-226.
7. Boku S., Nakagawa S., Masuda T., Nishikawa H., Kato A., Kitaichi Y., et al. Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3β and β-catenin/TCF pathway. Neuropsychopharmacology 2009, 34:805-815.
8. Brezun J.M., Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999, 89:999-1002.
9. DeVane C.L. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999, 19:443-466.
10. Dranovsky A., Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 2006, 59:1136-1143.
11. Duman R.S., Malberg J., Nakagawa S. Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther 2001, 299:401-407.
12. Encinas J.M., Vaahtokari A., Enikolopov G. Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A 2006, 103:8233-8238.
13. Eriksson P.S., Perfilieva E., Björk-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med 1998, 4:1313-1317.
14. Fuller R.W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 1994, 55:163-167.
15. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
16. Gould E., McEwen B.S., Tanapat P., Galea L.A.M., Fuchs E. Neurogenesis in dentate gyrus of adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 1997, 17:2492-2498.
17. Hisaoka K., Nishida A., Koda T., Miyata M., Zensho H., Morinobu S., et al. Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 2001, 79:25-34.
18. Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002, 71:533-554.
19. Jhaveri D.J., Mackay E.W., Hamlin A.S., Marathe S.V., Nandam L.S., Vaidya V.A., et al. Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J Neurosci 2010, 30:2795-2806.
20. Karson C.N., Newton J.E., Livingston R., Jolly J.B., Cooper T.B., Sprigg J., et al. Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci 1993, 5:322-329.
21. Kawakami N. Epidemiology of depressive disorders in Japan and the world. Nippon Rinsho 2007, 65:1578-1584.
22. Kelly M.W., Perry P.J., Holstad S.G., Garvey M.J. Serum fluoxetine and norfluoxetine concentrations and antidepressant response. Ther Drug Monit 1989, 11:165-170.
23. Kempermann G., Jessberger S., Steiner B., Kronenberg G. Milestones of neuronal development in the adult hippocampus. Trends Neurosci 2004, 27:447-452.
24. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
25. Kitaichi Y., Inoue T., Nakagawa S., Izumi T., Koyama T. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium. Eur J Pharmacol 2005, 516:219-226.
26. Krause M., Jia Y. Serotonergic modulation of carbachol-induced rhythmic activity in hippocampal slices. Neuropharmacology 2005, 48:381-390.
27. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 1995, 274:866-876.
28. Kulkarni V.A., Jha S., Vaidya V.A. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur J Neurosci 2002, 16:2008-2012.
29. Lai M., McCormick J.A., Chapman K.E., Kelly P.A., Seckl J.R., Yau J.L. Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture. Neuroscience 2003, 118:975-984.
30. Lecrubier Y., Puech A.J., Jouvent R., Simon P., Widlocher D. A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study. Br J Psychiatry 1980, 136:354-358.
31. Lerer B., Ebstein R.P., Belmaker R.H. Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression. Psychopharmacology (Berl) 1981, 75:169-172.
32. Malberg J., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
33. Mokler D.J., Torres O.I., Galler J.R., Morgane P.J. Stress-induced changes in extracellular dopamine and serotonin in the medial prefrontal cortex and dorsal hippocampus of prenatally malnourished rats. Brain Res 2007, 1148:226-233.
34. Mueller A.L., Hoffer B.J., Dunwiddie T.V. Noradrenergic responses in rat hippocampus: evidence for medication by alpha and beta receptors in the in vitro slice. Brain Res 1981, 214:113-126.
35. Nakagawa S., Kim J.E., Lee R., Malberg J.E., Chen J., Steffen C., et al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci 2002, 22:3673-3682.
36. Nakayama G.R., Caton M.C., Nova M.P., Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 1997, 204:205-208.
37. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996, 16:2365-2372.
38. O'Donnell J.M. Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol. J Pharmacol Exp Ther 1990, 254:147-157.
39. Pham K., Nacher J., Hof P.R., McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 2003, 17:879-886.
40. Pupo A.S., Minneman K.P. Adrenergic pharmacology: focus on the central nervous system. CNS Spectr 2001, 6:656-662.
41. Rizk P., Salazar J., Raisman-Vozari R., Marien M., Ruberg M., Colpaert F., et al. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 2006, 31:1146-1157.
42. Sacchetti G., Bernini M., Bianchetti A., Parini S., Invernizzi R.W., Samanin R. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br J Pharmacol 1999, 128:1332-1338.
43. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
44. Strauss W.L., Layton M.E., Hayes C.E., Dager S.R. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder. Am J Psychiatry 1997, 154:516-522.
45. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000, 20:4030-4036.
46. Warner-Schmidt J.L., Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006, 16:239-249.
47. Warner-Schmidt J.L., Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A 2007, 104:4647-4652.
48. Wong E.H., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F., Hoffmann W.P., et al. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 2000, 47:818-829.